new glp-1 receptor agonists Trends in the Development of GLP-1 Receptor Agonists as Treatments
Description
There's such a focus on metabolic care for obesity, and then they're like, oh cool, you guys also do diabetes and hypertension." Launched in 2011, Omada provides virtual care for diabetes, hypertension, musculoskeletal care, and diabetes prevention, alongside obesity, to employers, health plans, and even health systems
It's a peptide that mimics a hormone called glucagon-like peptide-1 (GLP-1), so they're called GLP-1 RAs, or receptor agonists (an agonist is something that produces a physiological response), and are administered by an injection
Our new Houston site will enhance Lillys ability to manufacture orforglipron at scale and, if approved, help fulfill the medicines potential as a metabolic health treatment for tens of millions of people worldwide who prefer the ease of a pill that can be taken without food and water restrictions, Lilly CEO David A
Hadjyanni et al
Meanwhile, changes in diastolic BP were variable and not significant
